Home/Filings/4/0000919574-24-003432
4//SEC Filing

Casdin Partners GP, LLC 4

Accession 0000919574-24-003432

CIK 0001818331other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 5:37 PM ET

Size

16.3 KB

Accession

0000919574-24-003432

Insider Transaction Report

Form 4
Period: 2024-05-29
Transactions
  • Purchase

    Class A Common Stock

    2024-05-29$21.07/sh+40,000$842,6042,963,509 total
Holdings
  • Class A Common Stock

    3,142
  • Class A Common Stock

    (indirect: See footnote(5).)
    333,144
  • Class A Common Stock

    (indirect: See footnote(4).)
    432,902
Casdin Capital, LLC
Director10% Owner
Transactions
  • Purchase

    Class A Common Stock

    2024-05-29$21.07/sh+40,000$842,6042,963,509 total
Holdings
  • Class A Common Stock

    (indirect: See footnote(5).)
    333,144
  • Class A Common Stock

    3,142
  • Class A Common Stock

    (indirect: See footnote(4).)
    432,902
Casdin Eli
Director10% Owner
Transactions
  • Purchase

    Class A Common Stock

    2024-05-29$21.07/sh+40,000$842,6042,963,509 total
Holdings
  • Class A Common Stock

    (indirect: See footnote(4).)
    432,902
  • Class A Common Stock

    3,142
  • Class A Common Stock

    (indirect: See footnote(5).)
    333,144
Casdin Partners GP, LLC
Director10% Owner
Transactions
  • Purchase

    Class A Common Stock

    2024-05-29$21.07/sh+40,000$842,6042,963,509 total
Holdings
  • Class A Common Stock

    3,142
  • Class A Common Stock

    (indirect: See footnote(5).)
    333,144
  • Class A Common Stock

    (indirect: See footnote(4).)
    432,902
Transactions
  • Purchase

    Class A Common Stock

    2024-05-29$21.07/sh+40,000$842,6042,963,509 total
Holdings
  • Class A Common Stock

    3,142
  • Class A Common Stock

    (indirect: See footnote(4).)
    432,902
  • Class A Common Stock

    (indirect: See footnote(5).)
    333,144
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $20.9752 to $21.1876. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  • [F2]The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.
  • [F3]The securities are owned directly by Eli Casdin.
  • [F4]The securities are owned directly by Casdin Partners FO1-MSV, LP ("Casdin FO1") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to Casdin FO1, (ii) the GP, the general partner of Casdin FO1, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC.
  • [F5]The securities are owned directly by CMLS Holdings LLC ("CMLS Holdings"). The Board of Managers of CMLS Holdings includes Eli Casdin, who, as a member of the Board of Managers of CMLS Holdings, shares voting and investment discretion with respect to the common stock held by CMLS Holdings

Documents

1 file

Issuer

GeneDx Holdings Corp.

CIK 0001818331

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001534260

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 5:37 PM ET
Size
16.3 KB